Bauta W - Search Results

1

Porphyrin-Modified Beads for Use as Compensation Controls in Flow Cytometry.

Bauta W, Grayson M, Titone R, Rebeles J, Rebel VI. Bauta W, et al. J Vis Exp. 2023 Mar 24;(193). doi: 10.3791/65294. J Vis Exp. 2023. PMID: 37036210

2

Effect of an ionic antineoplastic agent Cytoreg on blood chemistry in a Wistar rat model.

Villasana K, Quintero W, Montero Y, Pino C, Uzcategui O, Torres G, Prada M, Pozo L, Bauta W, Jimenez W. Villasana K, et al. Among authors: bauta w. Med Gas Res. 2022 Jan-Mar;12(1):18-23. doi: 10.4103/2045-9912.324592. Med Gas Res. 2022. PMID: 34472498 Free PMC article.

3

Evaluation of dermal corrosion and irritation by Cytoreg in rabbits.

Jimenez W, Gonzalez E, Murphy VA, Bauta W. Jimenez W, et al. Among authors: bauta w. Toxicol Rep. 2021 Jul 31;8:1527-1529. doi: 10.1016/j.toxrep.2021.07.021. eCollection 2021. Toxicol Rep. 2021. PMID: 34408971 Free PMC article.

4

Identification of a novel mechanism for meso-tetra (4-carboxyphenyl) porphyrin (TCPP) uptake in cancer cells.

Elzi DJ, Bauta WE, Sanchez JR, Das T, Mogare S, Zannes Fatland P, Iza M, Pertsemlidis A, Rebel VI. Elzi DJ, et al. Among authors: bauta we. FASEB J. 2021 Mar;35(3):e21427. doi: 10.1096/fj.202000197R. FASEB J. 2021. PMID: 33629776

5

Ebola virus. Two-pore channels control Ebola virus host cell entry and are drug targets for disease treatment.

Sakurai Y, Kolokoltsov AA, Chen CC, Tidwell MW, Bauta WE, Klugbauer N, Grimm C, Wahl-Schott C, Biel M, Davey RA. Sakurai Y, et al. Among authors: bauta we. Science. 2015 Feb 27;347(6225):995-8. doi: 10.1126/science.1258758. Science. 2015. PMID: 25722412 Free PMC article.

6

Design, synthesis, and characterization of novel, nonquaternary reactivators of GF-inhibited human acetylcholinesterase.

McHardy SF, Bohmann JA, Corbett MR, Campos B, Tidwell MW, Thompson PM, Bemben CJ, Menchaca TA, Reeves TE, Cantrell WR Jr, Bauta WE, Lopez A, Maxwell DM, Brecht KM, Sweeney RE, McDonough J. McHardy SF, et al. Among authors: bauta we. Bioorg Med Chem Lett. 2014 Apr 1;24(7):1711-4. doi: 10.1016/j.bmcl.2014.02.049. Epub 2014 Feb 28. Bioorg Med Chem Lett. 2014. PMID: 24630558

7

Targeting HER2-positive cancer with dolastatin 15 derivatives conjugated to trastuzumab, novel antibody-drug conjugates.

Gianolio DA, Rouleau C, Bauta WE, Lovett D, Cantrell WR Jr, Recio A 3rd, Wolstenholme-Hogg P, Busch M, Pan P, Stefano JE, Kramer HM, Goebel J, Krumbholz RD, Roth S, Schmid SM, Teicher BA. Gianolio DA, et al. Among authors: bauta we. Cancer Chemother Pharmacol. 2012 Sep;70(3):439-49. doi: 10.1007/s00280-012-1925-8. Epub 2012 Jul 22. Cancer Chemother Pharmacol. 2012. PMID: 22821053

8

Synthetic studies on formamidopyrimidines related to clofarabine.

Cantrell WR Jr, Lovett D, Engles T, Anderson B, Bauta WE, Wolstenholme-Hogg PC. Cantrell WR Jr, et al. Among authors: bauta we. Nucleosides Nucleotides Nucleic Acids. 2008 Aug;27(8):901-13. doi: 10.1080/15257770802257770. Nucleosides Nucleotides Nucleic Acids. 2008. PMID: 18696361

9

Preparation of a fludarabine intermediate via selective alkylation of 2-fluoroadenine.

Schulmeier BE, Cantrell WR Jr, Bauta WE. Schulmeier BE, et al. Among authors: bauta we. Nucleosides Nucleotides Nucleic Acids. 2006;25(7):735-45. doi: 10.1080/15257770600725960. Nucleosides Nucleotides Nucleic Acids. 2006. PMID: 16898412

10

Formal synthesis of angiogenesis inhibitor NM-3.

Bauta WE, Lovett DP, Cantrell WR Jr, Burke BD. Bauta WE, et al. J Org Chem. 2003 Jul 25;68(15):5967-73. doi: 10.1021/jo034165c. J Org Chem. 2003. PMID: 12868934

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

10 results

Search Page